Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer.
Sefrioui D, Perdrix A, Sarafan-Vasseur N, Dolfus C, Dujon A, Picquenot JM, Delacour J, Cornic M, Bohers E, Leheurteur M, Rigal O, Tennevet I, Thery JC, Alexandru C, Guillemet C, Moldovan C, Veyret C, Frebourg T, Di Fiore F, Clatot F. Sefrioui D, et al. Among authors: di fiore f. Int J Cancer. 2015 Nov 15;137(10):2513-9. doi: 10.1002/ijc.29612. Epub 2015 Jun 11. Int J Cancer. 2015. PMID: 25994408
Port catheter versus peripherally inserted central catheter for postoperative chemotherapy in early breast cancer: a retrospective analysis of 448 patients.
Lefebvre L, Noyon E, Georgescu D, Proust V, Alexandru C, Leheurteur M, Thery JC, Savary L, Rigal O, Di Fiore F, Veyret C, Clatot F. Lefebvre L, et al. Among authors: di fiore f. Support Care Cancer. 2016 Mar;24(3):1397-403. doi: 10.1007/s00520-015-2901-8. Epub 2015 Sep 5. Support Care Cancer. 2016. PMID: 26342484
Morbidity-mortality conference for adverse events associated with totally implanted venous access for cancer chemotherapy.
Merle V, Marini H, Di Fiore F, Lottin M, Gray C, Loeb A, Fred A, Contentin N, Muir JF, Thiberville L, Pfister C, Huet E, Peillon C, Michel P, Czernichow P. Merle V, et al. Among authors: di fiore f. Support Care Cancer. 2016 Apr;24(4):1857-63. doi: 10.1007/s00520-015-2969-1. Epub 2015 Oct 10. Support Care Cancer. 2016. PMID: 26454864
Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor.
Clatot F, Perdrix A, Augusto L, Beaussire L, Delacour J, Calbrix C, Sefrioui D, Viailly PJ, Bubenheim M, Moldovan C, Alexandru C, Tennevet I, Rigal O, Guillemet C, Leheurteur M, Gouérant S, Petrau C, Théry JC, Picquenot JM, Veyret C, Frébourg T, Jardin F, Sarafan-Vasseur N, Di Fiore F. Clatot F, et al. Among authors: di fiore f. Oncotarget. 2016 Nov 15;7(46):74448-74459. doi: 10.18632/oncotarget.12950. Oncotarget. 2016. PMID: 27801670 Free PMC article.
Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer.
Sefrioui D, Vermeulin T, Blanchard F, Chapusot C, Beaussire L, Armengol-Debeir L, Sesboué R, Gangloff A, Hebbar M, Copin MC, Houivet E, Schwarz L, Clatot F, Tuech JJ, Bénichou J, Martin L, Bouvier AM, Sabourin JC, Sarafan-Vasseur N, Frébourg T, Lepage C, Michel P, Di Fiore F. Sefrioui D, et al. Among authors: di fiore f. Int J Cancer. 2017 Apr 1;140(7):1653-1661. doi: 10.1002/ijc.30584. Int J Cancer. 2017. PMID: 28006840
ESR1 mutations in breast cancer.
Clatot F, Augusto L, Di Fiore F. Clatot F, et al. Among authors: di fiore f. Aging (Albany NY). 2017 Jan 25;9(1):3-4. doi: 10.18632/aging.101165. Aging (Albany NY). 2017. PMID: 28130553 Free PMC article. No abstract available.
184 results